Postgrad Med 134 , 1419 (2021)
Gebhardt B, Vlaho S, Fischer D, et al
Ozempic itself is FDA-approved for diabetes and (as Wegovy) for weight loss
Based on initial checks, there were no social media posts from close family members or friends confirming a womans death after taking the supplement in question
Funding This study/project is funded by the National Institute for Health Research (NIHR) Artificial Intelligence and Multimorbidity: Clustering in Individuals, Space and Clinical Context (AIM-CISC) grant NIHR202639

Research Outcomes by Gender Clinical trials of both cagrilintide and retatrutide have generally shown similar efficacy across genders, though some subtle differences emerge: Weight Loss Magnitude: Men often show slightly faster initial weight loss due to higher starting metabolic rates, but long-term outcomes typically converge Appetite Suppression: Women may report stronger satiety signals from amylin activation, while men may experience greater benefit from the energy expenditure effects of glucagon activation Body Composition: Men tend to preserve lean muscle mass better during weight loss with these peptides, possibly due to higher baseline testosterone levels Side Effect Tolerance: Women report slightly higher rates of nausea in some trials, though this difference is modest and may relate to hormonal factors For male researchers specifically interested in " what is cagrilintide for men ," the compound offers the same mechanism of action regardless of gender, with individual response variation being more significant than gender-based differences
